Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,859.00
Bid: 2,853.00
Ask: 2,855.00
Change: 15.00 (0.53%)
Spread: 2.00 (0.07%)
Open: 2,871.00
High: 2,881.00
Low: 2,837.00
Prev. Close: 2,844.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Action valuation

30 Jun 2016 07:00

RNS Number : 7191C
3i Group PLC
30 June 2016
 

30 June 2016

 

 

3i Group plc

Update on Action valuation

Since the publication of 3i Group plc's ("3i" or "the Group") financial results for the year to 31 March 2016, 3i has received a number of approaches in respect of Action, the Group's largest portfolio investment.

 

Action continues to grow strongly and, based on trading to mid-June, is performing on a trajectory similar to its 2015 performance with a similar level of like-for-like sales growth. Action is currently also on track to open materially more new stores this year than it did last year.

 

In light of the third-party interest in Action and its continuing growth and financial trajectory, the Board of 3i has decided to increase the book value of its investment in Action to £1,464 million1 after liquidity discount as at 30 June 2016 (31 March 2016: £902 million). This implies a post discount run-rate EBITDA multiple of 18.2x applied to the run-rate earnings as at 31 March 20162. The book valuation of £1,464 million amounts to a less than 15x projected run-rate EBITDA as at 31 December 20162 on the assumption that Action continues to grow on its current trajectory for the remainder of this calendar year.

 

3i is actively engaged in the further development of Action and is not intending to sell its investment or organise a flotation of Action in the near future.

 

We will publish our Q1 performance update on 27 July 2016, which will include this adjustment and the results of our quarterly portfolio valuation.

 

Notes

1. Action's valuation currency is euros. The GBP equivalents at 30 June 2016 in this update have been calculated at a currency exchange rate of €1.2168:£1.

 

2. Action is valued using a multiple of its run-rate earnings for the 12 months to the quarter end preceding the reporting period. The valuation uplift to £1,464 million at 30 June 2016 is calculated using run-rate earnings to 31 March 2016. The valuation as at 31 March 2017 will be calculated using run-rate earnings to 31 December 2016.

 

- Ends -

 

For further information, please contact:

 

Silvia SantoroInvestor Relations DirectorTel: 020 7975 3258

 

Toby Bates

Interim Communications DirectorTel: 020 7975 3032

 

 

About 3i Group

 

3i is a leading international investment manager focused on mid-market Private Equity, Infrastructure and Debt Management. Our core investment markets are northern Europe and North America. For further information, please visit: www.3i.com.

 

The financial information in this update is unaudited and is presented on 3i's non-GAAP Investment basis in order to provide users with the most appropriate description of the drivers of 3i's performance. Although this update has been prepared based on reasonable assumptions, any statements about the future outlook of 3i or its investments may be influenced by factors that could cause actual outcomes and results to be materially different.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUGPQUPQGRB
Date   Source Headline
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding
12th Jun 20232:33 pmRNSPublication of a Prospectus
9th Jun 20239:44 amRNSBlock listing Interim Review
8th Jun 20232:51 pmRNSDirector/PDMR Shareholding
7th Jun 202311:21 amRNSDTR 6.3.5
5th Jun 20233:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.